Search results
Texas rejects Centene, Elevance protests over alleged Aetna leak
Modern Healthcare· 2 days agoTexas denied allegations that local officials’ process for reviewing Medicaid managed care bids improperly advantaged rival CVS Health.
Cybersecurity Stocks To Watch Amid Shift To AI, Cloud
Investor's Business Daily· 2 days agoWith its Mandiant acquisition, Google-parent Alphabet also is making a big cybersecurity push. The...
Hedge Fund Favorites: 7 Stocks to Buy When You're Feeling Jittery
InvestorPlace· 4 days agoWith the market entering a historically challenging season (due to the adage buy in May and go...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Direct Digital Holdings ...
Oscar Health CEO Mark Bertolini is ready to take on the employer market
CNBC· 3 days agoMark Bertolini has helped Oscar Health move toward profitability after taking over as CEO of the...
Healing time: End date in sight for Ascension's ransomware restoration - Nashville Business Journal
The Business Journals· 6 days agoElectronic health records at Ascension Saint Thomas that were taken down by a ransomware attack...
Minnesota Fortune 500 roster grows by 2; UnitedHealth, U.S. Bancorp, C.H. Robinson among big movers...
The Business Journals· 5 days agoMinnesota gained clout on Fortune 500 roster this past year, as two Twin Cities companies joined the...
What Nvidia's stock split means for investors
Morningstar· 2 days agoNvidia Corp. shares have certainly seen momentum in the weeks since the company's stock-split announcement, rising 27% since the chip maker said on May 22 that it intended to conduct a 10-for ...
What Nvidia’s stock split means for investors
Market Watch· 3 days ago“I think it’s a muscle-memory thing, a function of investors buying because it worked in the past,” said Art Hogan, chief market strategist at B. Riley...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters· 3 days ago, opens new tab top-selling arthritis drug Humira has held onto more than 80% of patients after...